Carbohydrates as future anti-adhesion drugs for infectious diseases.

[1]  Michael S. Cohen,et al.  The Distinct Binding Specificities Exhibited by Enterobacterial Type 1 Fimbriae Are Determined by Their Fimbrial Shafts* , 2005, Journal of Biological Chemistry.

[2]  D. Cavallone,et al.  N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases , 2005, Glycoconjugate Journal.

[3]  C. Svanborg,et al.  Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. , 2005, International journal of medical microbiology : IJMM.

[4]  G. Ruiz-Palacios,et al.  Human milk glycans protect infants against enteric pathogens. , 2005, Annual review of nutrition.

[5]  Xi Jiang,et al.  Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. , 2005, The Journal of nutrition.

[6]  Lode Wyns,et al.  Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin , 2004, Molecular microbiology.

[7]  M. Disney,et al.  The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. , 2004, Chemistry & biology.

[8]  R. Pieters,et al.  Interference with Lectin Binding and Bacterial Adhesion by Multivalent Carbohydrates and Peptidic Carbohydrate Mimics , 2004 .

[9]  Hong-ying Huang,et al.  Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. , 2004, American journal of physiology. Renal physiology.

[10]  M. Chapman,et al.  Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. , 2004, The Journal of urology.

[11]  N. Roche,et al.  Helicobacter pylori and Complex Gangliosides , 2004, Infection and Immunity.

[12]  S. Hultgren,et al.  Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. , 2004, Kidney international.

[13]  A. Imberty,et al.  Structures of the lectins from Pseudomonas aeruginosa: insight into the molecular basis for host glycan recognition. , 2004, Microbes and infection.

[14]  N. Sharon,et al.  Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases , 2000, Glycoconjugate Journal.

[15]  N. Sharon,et al.  Anti-adhesion therapy of bacterial diseases: prospects and problems. , 2003, FEMS immunology and medical microbiology.

[16]  G. Porro,et al.  Treatment of Helicobacter Pylori Infection Using a Novel Antiadhesion Compound (3′sialyllactose sodium salt). A Double blind, Placebo‐Controlled Clinical Study , 2003, Helicobacter.

[17]  Lode Wyns,et al.  The fimbrial adhesin F17‐G of enterotoxigenic Escherichia coli has an immunoglobulin‐like lectin domain that binds N‐acetylglucosamine , 2003, Molecular microbiology.

[18]  Jörgen Ohlsson,et al.  Quantitative studies of the binding of the class II PapG adhesin from uropathogenic Escherichia coli to oligosaccharides. , 2003, Bioorganic & medicinal chemistry.

[19]  G. Ruiz-Palacios,et al.  Campylobacter jejuni Binds Intestinal H(O) Antigen (Fucα1, 2Galβ1, 4GlcNAc), and Fucosyloligosaccharides of Human Milk Inhibit Its Binding and Infection* , 2003, The Journal of Biological Chemistry.

[20]  P. Marcato,et al.  Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. , 2003, The Journal of infectious diseases.

[21]  I. Ofek,et al.  Bacterial adhesion to animal cells and tissues , 2003 .

[22]  S. Nishimura,et al.  Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands , 2002, Chembiochem : a European journal of chemical biology.

[23]  G. Waksman,et al.  Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection , 2002, Molecular microbiology.

[24]  C. Wagener,et al.  Binding inhibition of type 1 fimbriae to human granulocytes: a flow cytometric inhibition assay using trivalent cluster mannosides , 2001, Medical Microbiology and Immunology.

[25]  E. Sokurenko,et al.  Valency conversion in the type 1 fimbrial adhesin of Escherichia coli , 2001, Molecular microbiology.

[26]  T. Pokka,et al.  Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women , 2001, BMJ : British Medical Journal.

[27]  G. Waksman,et al.  Structural Basis of the Interaction of the Pyelonephritic E. coli Adhesin to Its Human Kidney Receptor , 2001, Cell.

[28]  S. Hultgren,et al.  Dynamic interactions between host and pathogen during acute urinary tract infections. , 2001, Urology.

[29]  E. Sokurenko,et al.  Molecular characterization of the Escherichia coli FimH adhesin. , 2001, The Journal of infectious diseases.

[30]  S. Langermann,et al.  Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. , 2001, The Journal of infectious diseases.

[31]  S. Hultgren,et al.  Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections. , 2001, The Journal of infectious diseases.

[32]  S. Abraham,et al.  Mast cell modulation of immune responses to bacteria , 2001, Immunological reviews.

[33]  N. Sharon,et al.  The structural basis for carbohydrate recognition by lectins. , 2001, Advances in experimental medicine and biology.

[34]  D. Zopf,et al.  Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial , 2000, The Lancet.

[35]  S. Koizumi,et al.  Large-scale production of oligosaccharides using engineered bacteria. , 2000, Current opinion in structural biology.

[36]  C. Kelly,et al.  Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces , 2000, Expert opinion on investigational drugs.

[37]  S. Normark.  Anfinsen comes out of the cage during assembly of the bacterial pilus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Pinkner,et al.  Type 1 pilus‐mediated bacterial invasion of bladder epithelial cells , 2000, The EMBO journal.

[39]  J. Hacker,et al.  Receptor Structure for F1C Fimbriae of Uropathogenic Escherichia coli , 2000, Infection and Immunity.

[40]  R. Read,et al.  Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.

[41]  S. Hultgren,et al.  Bacterial pili: molecular mechanisms of pathogenesis. , 2000, Current opinion in microbiology.

[42]  N. Sharon,et al.  Role of bacterial lectins in urinary tract infections. Molecular mechanisms for diversification of bacterial surface lectins. , 2000, Advances in experimental medicine and biology.

[43]  V. Stojanoff,et al.  X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. , 1999, Science.

[44]  Michael S. Cohen,et al.  Molecular Basis for the Enterocyte Tropism Exhibited bySalmonella typhimurium Type 1 Fimbriae* , 1999, The Journal of Biological Chemistry.

[45]  Scott J. Hultgren,et al.  Bacterial Adhesins: Common Themes and Variations in Architecture and Assembly , 1999, Journal of bacteriology.

[46]  D. Zopf,et al.  Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. , 1998, Gastroenterology.

[47]  D. Dykhuizen,et al.  Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Karlsson.  Meaning and therapeutic potential of microbial recognition of host glycoconjugates , 1998, Molecular microbiology.

[49]  R. Barthelson,et al.  Adherence of Streptococcus pneumoniae to Respiratory Epithelial Cells Is Inhibited by Sialylated Oligosaccharides , 1998, Infection and Immunity.

[50]  S. Normark,et al.  Fimbriae-mediated host-pathogen cross-talk. , 1998, Current opinion in microbiology.

[51]  E. Tuomanen,et al.  Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. , 1997, The Journal of infectious diseases.

[52]  Ankur H. Shah,et al.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. , 1997, The Journal of clinical investigation.

[53]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[54]  D. Zopf,et al.  Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides , 1997, Infection and immunity.

[55]  R. Roy,et al.  Syntheses and some applications of chemically defined multivalent glycoconjugates. , 1996, Current opinion in structural biology.

[56]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Sun,et al.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  D. Zopf,et al.  Oligosaccharide anti-infective agents , 1996, The Lancet.

[59]  J. Goldhar.  Erythrocytes as target cells for testing bacterial adhesins. , 1995, Methods in enzymology.

[60]  S. Teneberg,et al.  Characterization of gangliosides of epithelial cells of calf small intestine, with special reference to receptor-active sequences for enteropathogenic Escherichia coli K99. , 1994, Journal of biochemistry.

[61]  S. Clegg,et al.  Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins , 1994, Infection and immunity.

[62]  I. Blomfield,et al.  Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media , 1993, Journal of bacteriology.

[63]  N. Sharon,et al.  Lectinophagocytosis of type 1 fimbriated (mannose‐specific) Escherichia coli in the mouse peritoneum , 1992, Journal of leukocyte biology.

[64]  S. Normark,et al.  Saccharide orientation at the cell surface affects glycolipid receptor function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Mestecky,et al.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin , 1990, Infection and immunity.

[66]  J. Petit,et al.  Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis , 1990, Infection and immunity.

[67]  N. Sharon,et al.  Lectins as cell recognition molecules. , 1989, Science.

[68]  M. Kyogashima,et al.  Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine. , 1989, Archives of biochemistry and biophysics.

[69]  N. Sharon,et al.  Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria , 1988, Infection and immunity.

[70]  N. Sharon.  Bacterial lectins, cell‐cell recognition and infectious disease , 1987, FEBS letters.

[71]  N. Firon,et al.  Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells , 1987, Infection and immunity.

[72]  P. Klemm,et al.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.

[73]  F. Silverblatt,et al.  Effect of Tamm-Horsfall urinary glycoprotein on phagocytosis and killing of type I-fimbriated Escherichia coli , 1986, Infection and immunity.

[74]  W. Simpson,et al.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors , 1985, Infection and immunity.

[75]  N. Firon,et al.  Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria , 1984, Infection and immunity.

[76]  W. Simpson,et al.  Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli , 1983, The Journal of experimental medicine.

[77]  N. Firon,et al.  Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium. , 1983, Carbohydrate research.

[78]  N. Sharon,et al.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. , 1979, The Journal of infectious diseases.

[79]  E. Beachey,et al.  Mannose Binding and Epithelial Cell Adherence of Escherichia coli , 1978, Infection and immunity.

[80]  R. Williams,et al.  Inhibition of Bacterial Adherence by Secretory Immunoglobulin A: A Mechanism of Antigen Disposal , 1972, Science.